Birchview Capital as of Sept. 30, 2015
Portfolio Holdings for Birchview Capital
Birchview Capital holds 42 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 55.4 | $86M | 796k | 108.17 | |
Accelr8 Technology | 21.5 | $34M | 2.1M | 16.18 | |
Vermillion | 3.5 | $5.4M | 2.7M | 2.00 | |
Metabolix | 1.8 | $2.8M | 2.3M | 1.24 | |
EQT Corporation (EQT) | 1.8 | $2.7M | 42k | 64.78 | |
Contrafect | 1.3 | $2.0M | 455k | 4.45 | |
Hansen Medical | 1.3 | $2.0M | 528k | 3.76 | |
Masimo Corporation (MASI) | 0.9 | $1.4M | 37k | 38.55 | |
Medivation | 0.9 | $1.4M | 33k | 42.49 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $1.3M | 59k | 22.10 | |
Gilead Sciences (GILD) | 0.8 | $1.3M | 13k | 98.21 | |
Southwestern Energy Company (SWN) | 0.8 | $1.2M | 97k | 12.69 | |
Biolase Technology | 0.7 | $1.1M | 1.2M | 0.90 | |
Oncomed Pharmaceuticals | 0.6 | $974k | 59k | 16.60 | |
Continental Resources | 0.6 | $947k | 33k | 28.98 | |
Encana Corp | 0.6 | $852k | 132k | 6.44 | |
Quotient | 0.5 | $757k | 58k | 13.01 | |
Merck & Co (MRK) | 0.5 | $741k | 15k | 49.40 | |
Quidel Corporation | 0.5 | $736k | 39k | 18.88 | |
Sientra | 0.5 | $693k | 68k | 10.15 | |
Aegerion Pharmaceuticals | 0.4 | $626k | 46k | 13.61 | |
Accuray Incorporated (ARAY) | 0.4 | $602k | 120k | 5.00 | |
Tornier Nv | 0.4 | $612k | 30k | 20.40 | |
Cabot Oil & Gas Corporation (CTRA) | 0.3 | $459k | 21k | 21.86 | |
Ptc Therapeutics I (PTCT) | 0.3 | $451k | 17k | 26.69 | |
Neurocrine Biosciences (NBIX) | 0.2 | $386k | 9.7k | 39.79 | |
Celgene Corp right 12/31/2011 | 0.2 | $384k | 238k | 1.61 | |
Cerus Corporation (CERS) | 0.2 | $377k | 83k | 4.54 | |
Pioneer Natural Resources (PXD) | 0.2 | $365k | 3.0k | 121.67 | |
Merrimack Pharmaceuticals In | 0.2 | $360k | 42k | 8.51 | |
Advaxis | 0.2 | $364k | 36k | 10.22 | |
Raptor Pharmaceutical | 0.2 | $327k | 54k | 6.06 | |
Biogen Idec (BIIB) | 0.2 | $292k | 1.0k | 292.00 | |
Roka Bioscience | 0.2 | $297k | 152k | 1.95 | |
Transition Therapeutics | 0.2 | $261k | 146k | 1.79 | |
NxStage Medical | 0.1 | $232k | 15k | 15.78 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $240k | 3.4k | 70.59 | |
Oxford Immunotec Global | 0.1 | $207k | 15k | 13.53 | |
Puma Biotechnology (PBYI) | 0.1 | $162k | 2.2k | 75.35 | |
Xencor (XNCR) | 0.1 | $150k | 12k | 12.20 | |
Coherus Biosciences (CHRS) | 0.1 | $150k | 7.5k | 20.00 | |
PetroQuest Energy | 0.1 | $143k | 122k | 1.17 |